In one paragraphArticle in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
27 authors.
Yu-Ning HuangDepartment of Clinical Pharmacy, Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, California, 90089, USA.ORCID 0000-0003-1697-4267 Pooja Vinod JaiswalDepartment of Clinical Pharmacy, Alfred E. Mann School of Pharmacy, University of Southern California, Los Angeles, California, 90089, USA.ORCID 0009-0000-7957-3116 Anushka RajeshDepartment of Pharmacology and Pharmaceutical Sciences, Alfred E. Mann School of Pharmacy, University of Southern California, Los Angeles, CA, 90089, USA.ORCID 0000-0002-7729-0865 Anushka YadavDepartment of Pharmacology and Pharmaceutical Sciences, Alfred E. Mann School of Pharmacy, University of Southern California, Los Angeles, CA, USA.ORCID 0000-0002-4333-6028 Dottie YuDepartment of Quantitative and Computational Biology, Dana and David Dornsife College of Letters, Arts and Sciences, University of Southern California, Los Angeles, CA, USA.ORCID 0009-0004-5682-7362 Fangyun LiuDepartment of Quantitative and Computational Biology, Dana and David Dornsife College of Letters, Arts and Sciences, University of Southern California, Los Angeles, CA, USA.
Grace SchegDepartment of Quantitative and Computational Biology, Dana and David Dornsife College of Letters, Arts and Sciences, University of Southern California, Los Angeles, CA, USA.
Emma ShihDepartment of Biological Sciences, Dana and David Dornsife College of Letters, Arts and Sciences, University of Southern California, Los Angeles, CA, USA.
Grigore BoldirevDepartment of Computer Science, College of Arts and Sciences, Georgia State University, Atlanta, GA, 30303, USA.ORCID 0009-0008-8305-1650 Irina NakashidzeDepartment of Natural Sciences and Health Care, Batumi Shota Rustaveli State University, 6010, Batumi, Georgia.ORCID 0000-0001-8934-6312 Aditya SarkarSchool of Computing and Electrical Engineering, Indian Institute of Technology Mandi, North Campus, Kamand, Mandi, HP 175005, India.ORCID 0000-0002-4496-8289 Jay Himanshu MehtaDepartment of Pharmacology and Pharmaceutical Sciences, Alfred E. Mann School of Pharmacy, University of Southern California, Los Angeles, CA, USA.
Ke WangDepartment of Translational Genomics, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Khooshbu Kantibhai PatelDepartment of Clinical Pharmacy, Alfred E. Mann School of Pharmacy, University of Southern California, Los Angeles, California, 90089, USA.ORCID 0000-0002-7575-4734 Mustafa Ali Baig MirzaDepartment of Computer Science & Engineering, University of Bridgeport, Bridgeport, CT 06604, USA.
Kunali Chetan HapaniDepartment of Clinical Pharmacy, Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, California, 90089, USA.ORCID 0000-0002-7032-7952 Qiushi PengDepartment of Pharmacology and Pharmaceutical Sciences, Alfred E. Mann School of Pharmacy, University of Southern California, Los Angeles, CA, 90089, USA.ORCID 0000-0001-5051-3435 Ram AyyalaDepartment of Quantitative and Computational Biology, Dana and David Dornsife College of Letters, Arts and Sciences, University of Southern California, Los Angeles, CA, USA.ORCID 0000-0001-7275-271X Ruiwei GuoDepartment of Pharmacology and Pharmaceutical Sciences, Alfred E. Mann School of Pharmacy, University of Southern California, Los Angeles, CA, 90089, USA.ORCID 0000-0002-6978-8735 Shaunak KapurSeven Lakes High School, 9251 South Fry Road, Katy, Texas, 77494, United States of America.ORCID 0009-0007-8053-8167 Tejasvene RameshCenter for Personalized Cancer Therapy, University of Massachusetts Boston, Boston, MA, 02125, USA.ORCID 0000-0002-5021-1338 Dumitru CiorbăDepartment of Computers, Informatics and Microelectronics, Technical University of Moldova, Chisinau, 2045, Moldova.ORCID 0000-0002-3157-5072 Viorel MunteanuDepartment of Computers, Informatics and Microelectronics, Technical University of Moldova, Chisinau, 2045, Moldova.ORCID 0000-0002-4133-5945 Viorel BostanDepartment of Computers, Informatics and Microelectronics, Technical University of Moldova, Chisinau, 2045, Moldova.ORCID 0000-0002-2422-3538 Mihai DimianDepartment of Computers, Electronics and Automation, Stefan cel Mare University of Suceava, 720229 Suceava, Romania.ORCID 0000-0002-2093-8659 Malak S AbedalthagafiDepartment of Pathology & Laboratory Medicine, Emory University Hospital, Atlanta, GA, USA King Salman Center for Disability Research, Riyadh, Saudi Arabia.ORCID 0000-0003-1786-3366 Serghei MangulDepartment of Biological and Morphofunctional Sciences, College of Medicine and Biological Sciences, Stefan cel Mare University of Suceava, 720229 Suceava, Romania.ORCID 0000-0003-4770-3443 Funding
Advancing method benchmarking and data sharing through crowd-sourced competitions in cancer researchU24CA248265 · NCI · SAGE BIONETWORKS · PI BOUTROS, PAUL CHRISTOPHER, VARMA, SUSHEEL · 2020 to 2024
$4.1MDeveloping robust and scalable genomics tools and databases to analyze immune receptor repertoires across diverse populationsR01AI173172 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ALACHKAR, HOUDA · 2023 to 2025
$2.5MNCI NIH HHS U24 CA248265NIAID NIH HHS R01 AI173172
6 · The paper itselfAbstract
Recent advances in high-throughput sequencing technologies have made it possible to collect and share a massive amount of omics data, along with its associated metadata. Enhancing metadata availability is critical to ensure data reusability and reproducibility and to facilitate novel biomedical discoveries through effective data reuse. Yet, incomplete metadata accompanying public omics data may hinder reproducibility and reusability by reducing sample interpretability and limiting secondary analyses. In this study, we performed a comprehensive assessment of metadata completeness shared in both scientific publications and/or public repositories by analyzing over 253 studies encompassing over 164 thousands samples, including both human and non-human mammalian studies. We observed that studies often omit over a quarter of important phenotypes, with an average of only 74.8% of them shared either in the text of publication or the corresponding repository. Notably, public repositories alone contained 62% of the metadata, surpassing the textual content of publications by 3.5%. Only 11.5% of studies completely shared all phenotypes, while 37.9% shared less than 40% of the phenotypes. Studies involving non-human samples were more likely to share metadata than studies involving human samples. We observed similar results on the extended dataset spanning 2.1 million samples across over 61,000 studies from the Gene Expression Omnibus repository. The limited availability of metadata reported in our study emphasizes the necessity for improved metadata sharing practices and standardized reporting. Finally, we discuss the numerous benefits of improving the availability and quality of metadata to the scientific community and beyond, supporting data-driven decision-making and policy development in the field of biomedical research. This work provides a scalable framework for evaluating metadata availability and may help guide future policy and infrastructure development.
Identifiers
PMID40672350
PMCPMC12265520
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390